Lung Cancer Epidemiology in Korea
- PMID: 27669705
- PMCID: PMC5512360
- DOI: 10.4143/crt.2016.178
Lung Cancer Epidemiology in Korea
Abstract
Purpose: The current study was undertaken to examine the trends in the lung cancer incidence, mortality, and survival after a diagnosis in Korea.
Materials and methods: Lung cancer incidence data according to the histologic type and mortality data were obtained from the Korea Central Cancer Registry and the Statistics Korea, respectively. The age-standardized incidence and mortality rates were calculated, and the Joinpoint model and age-period-cohort analyses were used to describe the trends in the rates. The 5-year relative survival rates of lung cancer were also calculated.
Results: Although the number of new lung cancer cases increased between 1999 and 2012, the age-standardized incidence rate decreased by 0.9% per year in men, whereas the incidence in women increased by 1.7% per year over the same time. Until 2010, the most common histologic type in men was squamous cell carcinoma, then adenocarcinoma prevailed thereafter. Since 1999, the most frequent histological type in women was adenocarcinoma. The lung cancer mortality started to decrease in 2002, with a more apparent decline for the younger age groups in both men and women. Overall, the 5-year relative survival rates have improved significantly from 11.2% for men and 14.7% for women among patients diagnosed between 1993 and 1997 to 19.3% for men and 28.2% for women among patients diagnosed between 2008 and 2012, respectively. An improvement in survival rate was observed for all major histology groups.
Conclusion: The epidemiology of lung cancer in Korea has changed over a short time span, with decreasing mortality and improving survival rates. Further study is warranted to determine the cause of these changes.
Keywords: Adenocarcinoma; Epidemiology; Incidence; Lung neoplasms; Mortality; Survival.
Conflict of interest statement
Conflict of interest relevant to this article was not reported.
Figures
References
-
- GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 . All cancers (excluding nonmelanoma skin cancer) estimated incidence, mortaliy and prevalence worldwide in 2012 [Internet] Geneva: World Health Organization; 2015. [cited 2015 Nov 13]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx#.
-
- Devesa SS, Shaw GL, Blot WJ. Changing patterns of lung cancer incidence by histological type. Cancer Epidemiol Biomarkers Prev. 1991;1:29–34. - PubMed
-
- Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer. 2003;41:245–58. - PubMed
-
- Jemal A, Chu KC, Tarone RE. Recent trends in lung cancer mortality in the United States. J Natl Cancer Inst. 2001;93:277–83. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
